This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a prescription medication, with a ceiling value of $13,846.97 and a performance period ending on July 8, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business type. Amerisourcebergen Drug...
This is a $13,846.97 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the pharmaceutical product VYNDAQEL 20 MG CAPSULE UD 120S. The contract has a period of performance through July 7, 2025 and is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $25,920.62, is for the supply of VYNDAQEL 20MG CAP 120S, a medication, and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of the medication VYNDAQEL 20 MG CAPSULE UD 120S to the Defense Logistics Agency (DLA). The firm-fixed-price, $13,408.24 delivery order has a completion date of February 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,846.97, is for the supply of the prescription drug VYNDAQEL 20 MG CAPSULE UD 120S. It is a firm fixed-price contract with a period of performance through May 20, 2025. The contract is not designated as a set-aside and was openly competed. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm-fixed-price contract is for the supply of the drug VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of February 3, 2025. The award is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.23 firm fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of VYNDAQEL 20 MG capsules. The contract has a ceiling value of $12,345.34 and a performance period through April 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary vehicle for AmerisourceBergen Drug...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,345.34 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract, which has a completion date of March 12, 2024, is for the provision of 120 capsules of the pharmaceutical product VYNDAQEL 20 MG. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,960.30 firm fixed-price contract is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty pharmaceutical product. The contract has a period of performance through September 3, 2024 and was awarded on August 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA...